Literature DB >> 33407504

LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis.

Peng Zhao1, Jianhua Cheng2, Bin Li2, Ding Nie2, Hongyun Wang3, Chuzhong Li3, Songbai Gui2, Yazhuo Zhang2.   

Abstract

BACKGROUND: Dysregulated lncRNA PCAT6 was discovered in many cancers excluding pituitary adenomas (PA). Therefore, we explored the role of PCAT6 in PA in this research.
METHODS: Abnormally expressed miRNAs were analyzed by bioinformatics and RT-qPCR. The target and regulator of miR-139-3p were determined by bioinformatics, dual-luciferase reporter assay, or RIP. The correlation among PCAT6, miR-139-3p, and BRD4 was further analyzed. The viability, apoptosis, cell cycle distribution of PA cells, as well as their ability to invade, migrate, and proliferate, were tested after transfection through CCK-8, flow cytometry, transwell, wound healing, and colony formation assays. After construction of transplanted-tumor model in nude mice, cell apoptosis in the tumor was detected by TUNEL. The expressions of PCAT6, BRD4, miR-139-3p, and apoptosis-related factors in PA tissues, cells, or tumor tissues were detected by RT-qPCR, Western blot, or IHC.
RESULTS: PCAT6 and BRD4 were high-expressed but miR-139-3p was low-expressed in PA. Both the 3'-untranslated regions of PCAT6 and BRD4 mRNAs were demonstrated to contain a potential binding site for miR-139-3p. PCAT6 was positively correlated to BRD4, and miR-139-3p was negatively correlated to PCAT6 and BRD4. MiR-139-3p mimic, shPCAT6 and siBRD4 inhibited the viability, migration, invasion, and proliferation of PA cells while inducing apoptosis. MiR-139-3p mimic and shPCAT6 inhibited the cell cycle progression of PA cells, decreased the weight and volume of the xenotransplanted tumor, and reduced the levels of Bcl-2 and BRD4 while enhancing the levels of Bax, miR-139-3p, and Cleaved caspase-3. MiR-139-3p inhibitor caused the opposite effect of miR-139-3p mimic and further reversed the effect of shPCAT6 on on PA cells.
CONCLUSION: PCAT6 regulated the progression of PA via modulating the miR-139-3p/BRD4 axis, which might provide a novel biomarker for the prevention, diagnosis, and treatment of PA.

Entities:  

Keywords:  BRD4; Pituitary adenomas; Xenotransplanted-tumor; lncRNA PCAT6; miR-139-3p

Year:  2021        PMID: 33407504     DOI: 10.1186/s12935-020-01698-7

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  31 in total

Review 1.  Surgery for Pediatric Pituitary Adenomas.

Authors:  Alexandria C Marino; Davis G Taylor; Bhargav Desai; John A Jane
Journal:  Neurosurg Clin N Am       Date:  2019-07-05       Impact factor: 2.509

2.  Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.

Authors:  Haibo Zhu; Jing Guo; Yutao Shen; Wei Dong; Hua Gao; Yazhou Miao; Chuzhong Li; Yazhuo Zhang
Journal:  Clin Cancer Res       Date:  2018-07-06       Impact factor: 12.531

3.  Expression analysis of vimentin and the related lncRNA network in breast cancer.

Authors:  Mehdi Mohebi; Soudeh Ghafouri-Fard; Mohammad Hossein Modarressi; Sepideh Dashti; Ali Zekri; Vahid Kholghi-Oskooei; Mohammad Taheri
Journal:  Exp Mol Pathol       Date:  2020-04-10       Impact factor: 3.362

4.  Pituitary Adenomas with Changing Phenotype: A Systematic Review.

Authors:  Fernando Guerrero-Pérez; Agustina Pia Marengo; Noemi Vidal; Carles Villabona
Journal:  Exp Clin Endocrinol Diabetes       Date:  2020-04-14       Impact factor: 2.949

5.  Impact of transsphenoidal surgery for pituitary adenomas on overall health-related quality of life: a longitudinal cohort study.

Authors:  Hanne Sommerfelt; Lisa Millgård Sagberg; Ole Solheim
Journal:  Br J Neurosurg       Date:  2019-09-22       Impact factor: 1.596

6.  Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior.

Authors:  Zhenye Li; Chuzhong Li; Chunhui Liu; Shengyuan Yu; Yazhuo Zhang
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

7.  Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.

Authors:  Tianyu Lu; Chen Yu; Hongbin Ni; Weibang Liang; Huiying Yan; Wei Jin
Journal:  Int J Dev Neurosci       Date:  2018-03-28       Impact factor: 2.457

8.  Construction of lncRNA regulatory networks reveal the key lncRNAs associated with Pituitary adenomas progression.

Authors:  Yong Hua Xue; Yi Qin Ge
Journal:  Math Biosci Eng       Date:  2020-01-06       Impact factor: 2.080

9.  Clinical study of endoscopic treatment of a sellar pituitary adenomas with sellar diaphragm defect.

Authors:  Zhuoru Jin; Xinyu Wu; Yibao Wang
Journal:  BMC Neurol       Date:  2020-04-11       Impact factor: 2.474

10.  Delayed Hyponatremia Following Surgery for Pituitary Adenomas: An Under-recognized Complication.

Authors:  Simon Rajaratnam; Lakshmanan Jeyaseelan; Vedantam Rajshekhar
Journal:  Neurol India       Date:  2020 Mar-Apr       Impact factor: 2.117

View more
  5 in total

1.  MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.

Authors:  Xiaoyu Zheng; Yingchun Zhang; Shaojun Wu; Bin Jiang; Yongchun Liu
Journal:  Mol Biotechnol       Date:  2022-02-12       Impact factor: 2.695

2.  miR-124a Involves in the Regulation of Wnt/β-Catenin and P53 Pathways to Inhibit Abdominal Aortic Aneurysm via Targeting BRD4.

Authors:  Yunhui Li; Meifeng Lv; Mingshu Lu; Hongliang Guan
Journal:  Comput Math Methods Med       Date:  2022-01-21       Impact factor: 2.238

Review 3.  PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers.

Authors:  Feng Jiang; Qiaoyi Lv; Cexun Hu; Zhanghui Li; Haojie Wu; Shujun Gao; Hui Wang; Yangjing Zhao; Qixiang Shao
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

Review 4.  The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma.

Authors:  Soudeh Ghafouri-Fard; Atefe Abak; Bashdar Mahmud Hussen; Mohammad Taheri; Guive Sharifi
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 5.  MicroRNA-139, an Emerging Gate-Keeper in Various Types of Cancer.

Authors:  Christiaan J Stavast; Iris van Zuijen; Stefan J Erkeland
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.